Next Century Growth Investors Portfolio holdings

Next Century Growth Investors's Q2 2021 Portfolio in Review

As of Q2 2021, Next Century Growth Investors held 136 positions worth $1.28B, down 2.3% from $1.31B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Next Century Growth Investors withdrew a net $157M in Q2 2021, closing 9 positions and reducing 96 holdings. Its most notable exit was Veracyte, an estimated $17.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, up from 36% a quarter earlier, followed by Technology and Industrials.

Against the trend, Next Century Growth Investors opened a new position in Treace Medical Concepts worth $31.1M.

• Next Century Growth Investors's largest Q2 2021 buy was Treace Medical Concepts: 994,351 shares worth $31.1M.
• Next Century Growth Investors added most to Telos in Q2 2021, an estimated $10.4M increase.
• Next Century Growth Investors's biggest Q2 2021 reduction was Sprout Social, cutting an estimated $19M.
• Next Century Growth Investors fully exited Veracyte in Q2 2021, selling an estimated $17.5M.
• Next Century Growth Investors's ten largest holdings make up 28% of its $1.28B portfolio in Q2 2021.
• Next Century Growth Investors opened 7 new positions and closed 9 in Q2 2021.
• Next Century Growth Investors's portfolio value fell 2.3% quarter-over-quarter to $1.28B.

Based on Next Century Growth Investors's 13F filing for Q2 2021, filed 13 Aug 2021.